IDI

International Drug Agency for Pharmaceutical Industry (IDI) is a private Egyptian pharmaceutical manufacturer and supplier focused primarily on commercialized generic medicines and related healthcare products. The company operates as part of an Egyptian pharmaceutical group and manufactures dosage forms including tablets, capsules, and dry powders for local distribution and export. Its portfolio spans multiple therapeutic categories such as anti-diabetics, cardiovascular, gastrointestinal, anti-viral, anti-depressant, antibiotic, and dietary supplement products. Available sources indicate that IDI serves healthcare providers, institutions, and hospital channels, and has export activity in selected regional markets. The company appears to be commercially operating rather than a clinical-stage biotech innovator, with emphasis on manufacturing, packaging, testing, storage, distribution, and generic product commercialization.